Lysergic acid diethylamide is under clinical development by Mind Medicine MindMed and currently in Phase II for Major Depressive Disorder.

A groundbreaking clinical trial has revealed that nerve-stimulating therapy can bring significant improvements to people with ...

Neumora Therapeutics to release phase 3 data on Navacaprant for MDD treatment in 2024. Check out NMRA's catalysts that might ...

The study focused on 78 participants diagnosed with major depressive disorder who also had strong suicidal thoughts ... Its ...

Transcranial magnetic stimulation for alcohol use disorders is under investigation. Research to date suggests TMS could play ...

If you or a loved one is struggling with anxiety or depression, contact the Substance Abuse and Mental Health Services Administration (SAMHSA) National Helpline at 800-662-4357 for information on ...

If you’ve been diagnosed with clinical depression, also known as major depressive disorder (MDD), rest assured there are many treatment options available. Some people will experience only one ...

Even though there are now many ways to communicate through technology, I still believe that handwritten letters remain an ...

Avoiding meat—especially highly processed meat and meat rich in saturated fat—has long been linked with lower incidence of ...

What is true is that rates of depression and stress typically increase at this times of year. If Santa brings you the holiday blues, here are 10 tools to restore some emotional balance.

People with severe, treatment-resistant depression who received a nerve-stimulating therapy showed significant improvement in ...